🚀 ProPicks AI Hits +34.9% Return!Read Now

Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket

Published 09/10/2023, 13:20
Updated 09/10/2023, 14:40
© Reuters.  Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket
AVID
-

Benzinga - by Lisa Levin, Benzinga Editor.

Gainers

Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclosed the launch of Jupiter Drones, an innovative, drone-oriented solution based on Maris-Tech's Jupiter Nano platform.

ParaZero Technologies Ltd. (NASDAQ: PRZO) shares gained 27.6% to $1.48 in pre-market trading. ParaZero Technologies shares surged 79% on Friday after the company and its partner OVRL announced the first-ever authorization from Australia's Civil Aviation Safety Agency for drones to operate over populated areas and near people when using ParaZero safety systems.

Roadzen, Inc. (NASDAQ: RDZN) shares rose 13.5% to $5.22 in pre-market trading, after gaining 11% on Friday.

Nxu, Inc. (NASDAQ: NXU) shares climbed 13.3% to $0.17 in pre-market trading after falling 15% on Friday.

Molekule Group, Inc. (NASDAQ: MKUL) rose 11.2% to $0.1369 in pre-market trading. Molekule Group, on Oct. 4, received delisting notice from Nasdaq notifying company’s common stock will be delisted from Nasdaq on Oct. 13

Avidity Biosciences, Inc. (NASDAQ: RNA) rose 9.1% to $6.75 in pre-market trading after the company disclosed new positive AOC 1001 data demonstrating improvement in multiple additional functional endpoints and favorable long-term safety and tolerability in people living with myotonic dystrophy type 1.

Better Therapeutics, Inc. (NASDAQ: BTTX) shares jumped 8.8% to $0.3698 in pre-market trading. Better Therapeutics recently reported the pre-print publication of the LivVita study's results in Gastro Hep Advances.

XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 8.7% to $0.30 in pre-market trading, after falling around 23% on Friday.

Oblong, Inc. (NASDAQ: OBLG) shares surged 8.2% to $0.3299 in pre-market trading, after gaining more than 6% on Friday.

Nvni Group Limited (NASDAQ: NVNI) shares rose 7.5% to $4.00 in pre-market trading, after gaining 7% on Friday.

Losers

Shift Technologies, Inc. (NASDAQ: SFT) fell 85% to $0.2846 in pre-market trading. Shift Technologies said it and its subsidiaries intend to file a voluntary Chapter 11 petition

LQR House Inc. (NASDAQ: LQR) fell 33.7% to $0.2551 in pre-market trading.

Kubient, Inc. (NASDAQ: KBNT) shares fell 21.2% to $0.2160 in pre-market trading. On Oct. 2, Kubient reduced expenses by implementing an 36% reduction in the company's workforce.

Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) shares fell 14.8% to $1.09 in pre-market trading, after declining 18% on Friday.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares fell 12.1% to $0.2826 in pre-market trading after dipping around 32% on Friday. Novo Integrated Sciences recently signed a One Billion Dollar Master Collateral Transfer Agreement with Blacksheep Trust for the purpose and general use of monetization for a period of up to 15 years.

IceCure Medical Ltd (NASDAQ: ICCM) fell 10.7% to $0.7810 in pre-market trading. IceCure Medical recently said that the findings from an independent breast cancer study, performed by a leading radiologist in Italy, support the safety and efficacy of ProSense, a minimally-invasive cryoablation system3.

Tempo Automation Holdings, Inc. (NASDAQ: TMPO) shares fell 9.4% to $0.1494 in pre-market trading after gaining 18% on Friday.

Vascular Biogenics Ltd. (NASDAQ: VBLT) fell 9.1% to $0.2272 in pre-market trading. Vascular Biogenics, during August, posted a narrower loss for the second quarter.

Avinger, Inc. (NASDAQ: AVGR) fell 8.8% to $4.01 in pre-market. Avinger recently received a notice of allowance for its U.S. patent application 17/449,867 titled "Occlusion-Crossing Devices, Imaging, And Atherectomy Devices."

Femasys Inc. (NASDAQ: FEMY) shares fell 7.5% to $1.85 in pre-market trading.

Now Read This: Top 4 Health Care Stocks That Are Preparing To Pump This Quarter

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.